Iantrek develops technology for minimally invasive microinvasive glaucoma surgery.
Iantrek has raised $30.0M in total funding. The most recent round was Debt Financing. The last funding was announced in April 2026.
Iantrek's investors include U.S. Venture Partners, Trinity Capital, Civilization Ventures, Visionary Venture Fund, aMoon Fund.
Iantrek is headquartered in White Plains, United States.
Iantrek develops technology for minimally invasive microinvasive glaucoma surgery.
Iantrek is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Iantrek — Funding & Investors." VCBacked, April 28, 2026, https://www.vcbacked.co/company/iantrek. Accessed October 30, 2026.
VCBacked. (2026). Iantrek — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/iantrek
{{cite web |title=Iantrek — Funding & Investors |url=https://www.vcbacked.co/company/iantrek |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated